UM1TR005466
Cooperative Agreement
Overview
Grant Description
Southwest Center for Advancing Clinical and Translational Innovation (SW CACTI) - Summary to improve and advance health in the United States Southwest region, the University of New Mexico (UNM) and University of Arizona have partnered to form the Southwest Center for Advancing Clinical and Translational Innovation (SW CACTI) to remove barriers to translational science, accelerate clinical translational innovation, and advance health equity.
Since its inception in 2010, the National Center for Advancing Translational Sciences (NCATS)-funded UNM Clinical and Translational Science Center (CTSC) has had a transformational impact on the scientific landscape of New Mexico.
Building on this success, our new visionary partnership will address common regional health concerns, including disproportionately burdensome conditions affecting rural, minority, and other underserved populations, and extreme poverty, unique geography, and barriers to equitable and quality healthcare access.
Critically, the distinctive demographics of our region require research conducted with a deep respect for cultural and historical context to lower barriers to research translation through clinical and translational science (CTS) and demands the growth of a skilled and diverse clinical and translational research (CTR) workforce.
SW CACTI and our respective institutional leadership are committed to creating, monitoring, and maintaining successful, responsible, easily accessible research environments with an ethos of collaboration and inclusivity.
We will accelerate our effectiveness and meaningfully advance the vision of SW CACTI and the NCATS CTSA program by achieving measurable goals and objectives for a thriving CTS environment.
In Aim 1, we will discover scientific and operational CTS innovations within the SW CACTI partnership and adopt externally developed innovations supported by new cross-cutting workgroups in key areas that intersect with and augment the scientific, outreach, and training activities of the CTSA consortium.
These workgroups focus on learning health systems, team science, justice, equity, diversity and inclusion, dissemination and implementation, and comprehensive evaluation alongside continuous quality improvement.
In Aim 2, we will engage and serve diverse SW communities through people- and patient-centric trust-building strategies and CTS experimental approaches that identify, employ, and disseminate best practices in equity, accessibility, and inclusion for CTR, multidisciplinary workforce development, and community outreach.
In Aim 3, we will provide cutting-edge research resources and services to address vital needs and critical barriers and to catalyze innovations across the multiple stages of CTS.
Lastly, in Aim 4, we will expand innovative CTS training platforms with a range of opportunities across multiple workforce development areas, including a clinical research staff professional career pathway program that facilitates high-quality CTS/R and addresses clinical and biomedical challenges unique to our region.
Our programs address diverse representation, reflecting our demographics to overcome critical CTS barriers.
Since its inception in 2010, the National Center for Advancing Translational Sciences (NCATS)-funded UNM Clinical and Translational Science Center (CTSC) has had a transformational impact on the scientific landscape of New Mexico.
Building on this success, our new visionary partnership will address common regional health concerns, including disproportionately burdensome conditions affecting rural, minority, and other underserved populations, and extreme poverty, unique geography, and barriers to equitable and quality healthcare access.
Critically, the distinctive demographics of our region require research conducted with a deep respect for cultural and historical context to lower barriers to research translation through clinical and translational science (CTS) and demands the growth of a skilled and diverse clinical and translational research (CTR) workforce.
SW CACTI and our respective institutional leadership are committed to creating, monitoring, and maintaining successful, responsible, easily accessible research environments with an ethos of collaboration and inclusivity.
We will accelerate our effectiveness and meaningfully advance the vision of SW CACTI and the NCATS CTSA program by achieving measurable goals and objectives for a thriving CTS environment.
In Aim 1, we will discover scientific and operational CTS innovations within the SW CACTI partnership and adopt externally developed innovations supported by new cross-cutting workgroups in key areas that intersect with and augment the scientific, outreach, and training activities of the CTSA consortium.
These workgroups focus on learning health systems, team science, justice, equity, diversity and inclusion, dissemination and implementation, and comprehensive evaluation alongside continuous quality improvement.
In Aim 2, we will engage and serve diverse SW communities through people- and patient-centric trust-building strategies and CTS experimental approaches that identify, employ, and disseminate best practices in equity, accessibility, and inclusion for CTR, multidisciplinary workforce development, and community outreach.
In Aim 3, we will provide cutting-edge research resources and services to address vital needs and critical barriers and to catalyze innovations across the multiple stages of CTS.
Lastly, in Aim 4, we will expand innovative CTS training platforms with a range of opportunities across multiple workforce development areas, including a clinical research staff professional career pathway program that facilitates high-quality CTS/R and addresses clinical and biomedical challenges unique to our region.
Our programs address diverse representation, reflecting our demographics to overcome critical CTS barriers.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
New Mexico
United States
Geographic Scope
State-Wide
University Of New Mexico was awarded
SW CACTI: Advancing Clinical & Translational Innovation
Cooperative Agreement UM1TR005466
worth $5,575,236
from National Center for Advancing Translational Sciences in August 2025 with work to be completed primarily in New Mexico United States.
The grant
has a duration of 6 years 10 months and
was awarded through assistance program 93.350 National Center for Advancing Translational Sciences.
The Cooperative Agreement was awarded through grant opportunity Clinical and Translational Science Award (UM1 Clinical Trial Optional).
Status
(Ongoing)
Last Modified 8/6/25
Period of Performance
8/1/25
Start Date
6/30/32
End Date
Funding Split
$5.6M
Federal Obligation
$0.0
Non-Federal Obligation
$5.6M
Total Obligated
Activity Timeline
Additional Detail
Award ID FAIN
UM1TR005466
SAI Number
UM1TR005466-1934705062
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NR00 NIH National Center for Advancing Translational Sciences
Funding Office
75NR00 NIH National Center for Advancing Translational Sciences
Awardee UEI
G389MFAYJNG9
Awardee CAGE
5DF80
Performance District
NM-90
Senators
Martin Heinrich
Ben Luján
Ben Luján
Modified: 8/6/25